Circulating Tumor DNA Status and Adjuvant Chemotherapy in Resected Colorectal Liver Metastases

Дата публикации: 03-07-2026 00:00:00

This prognostic study evaluates the association between circulating tumor DNA–defined molecular residual disease and survival outcomes and whether molecular residual disease status is associated with differential benefit from adjuvant chemotherapy in resected colorectal liver metastases.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Circulating Methylated SEPT9 for Detection of Hepatocellular Carcinoma in Cirrhosis	0	7	02-07-2026
2	Effect of Neoadjuvant Therapy on Postoperative Complications in Colorectal Cancer: A Multicenter Prospective Propensity-Matched Cohort Study	0	5	16-07-2026
3	Race, Secondary Treatment, and Survival in Localized Prostate Cancer	0	5.24	21-07-2026
4	Troponin Screening and Major Cardiovascular Adverse Events During ICI Therapy	0	7.02	21-07-2026
5	Federal Housing Assistance and Survival in Older Adults With NSCLC	0	8.64	30-07-2026
6	Lung transplant dramatically improves survival for patients with terminal lung cancer, study finds	7	8	08-07-2026
7	When Not to Push the Boulder	0	5	02-07-2026
8	Medically Assisted Reproduction and Hormone-Related Cancers	0	5	13-07-2026
9	Ultrasensitive blood test predicts head and neck cancer relapse months earlier	5	7	10-06-2026
10	Cardiac Risk After Heart-Sparing Breast Radiotherapy	0	5	02-07-2026

Классификация: Пресс-релизы. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 7. Источник: jamanetwork.com.